(Q33564477)

28 July 2017

1 reference

title

Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis (English)

1 reference

28 July 2017

0 references

H. A. Capell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1575601

10 October 2022

M. Brzeski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1575601

10 October 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

full work available at URL

28 July 2017

https://europepmc.org/articles/PMC1004681

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1575601

https://europepmc.org/articles/PMC1004681?pdf=render

10 October 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1575601

Annals of the Rheumatic Diseases

10 October 2022

published in

1 reference

28 July 2017

51

1 reference

28 July 2017

3

1 reference

28 July 2017

424-429

1 reference

Long‐term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response [letter]

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Does the order of second-line treatment in rheumatoid arthritis matter?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Does the addition of ketotifen to non-steroidal anti-inflammatory drugs confer any additional benefit in rheumatoid arthritis?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Chrysotherapy and thrombocytopenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Anti-rheumatic drugs and joint damage in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Seatone in rheumatoid arthritis: a six-month placebo-controlled study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Effect of sulphasalazine on the radiological progression of rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Remodeling the pyramid--a concept whose time has come

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Rifampin therapy in rheumatoid arthritis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Winning the battle, losing the war? Another editorial about rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Rheumatoid arthritis. Pathophysiology and implications for therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Proposition: methotrexate should not be the first second-line agent to be used in rheumatoid arthritis if NSAIDs fail

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Risk factors of second-line antirheumatic drugs in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Use of the radiograph to measure the course of rheumatoid arthritis. The gold standard versus fool's gold

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004681

Timegadine: more than a non-steroidal for the treatment of rheumatoid arthritis. A controlled, double-blind study

31 October 2018

1 reference

12 December 2020

A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis

1 reference

12 December 2020

Study of sulphamethoxazole in rheumatoid arthritis

1 reference

12 December 2020

The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol

1 reference

12 December 2020

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

1 reference

12 December 2020

Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate

1 reference

12 December 2020

Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period

1 reference

12 December 2020

Sulphasalazine and ankylosing spondylitis

1 reference

12 December 2020

Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up

1 reference

12 December 2020

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone

1 reference

12 December 2020

Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial

1 reference

12 December 2020

Estrogen use and radiographic osteoarthritis of the knee in women

1 reference

12 December 2020

Minocycline treatment for rheumatoid arthritis: an open dose finding study

1 reference

12 December 2020

Captopril: a new treatment for rheumatoid arthritis?

1 reference

12 December 2020

Development of antinuclear antibody in patients treated with high doses of captopril

1 reference

12 December 2020

A double-blind comparative study of metronidazole and placebo in rheumatoid arthritis

1 reference

12 December 2020

Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?

1 reference

12 December 2020

Suppress rheumatoid inflammation early and leave the pyramid to the Egyptians

1 reference

12 December 2020

A double blind placebo controlled trial of low dose clotrimazole in rheumatoid arthritis

1 reference

12 December 2020

Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy

1 reference

12 December 2020

Selection of suitable patients for second-line therapy in rheumatoid arthritis

1 reference

12 December 2020

Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study

1 reference

12 December 2020

Acetylator phenotypes in rheumatoid arthritis patients with or without adverse drug reactions to sodium-aurothiomalate or d-penicillamine

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.51.3.424

1 reference

28 July 2017

1 reference

28 July 2017

1 reference